Adial Pharmaceuticals ADIL
-
-
-
已收盤：-
本益比明細
年季 | 收盤價 | 本業佔比% | 本益比(近四季) | 每股稅後盈餘(元) | 營業利益(千) | 稅後純益(百萬) |
|---|---|---|---|---|---|---|
| 2025Q4 | 5.50 | 102.33 | -0.68 | -1,885 | -2 | |
| 2025Q3 | 8.84 | 102.74 | 1.00 | -1,764 | -2 | |
| 2025Q2 | 7.56 | 101.24 | -3.75 | -1,883 | -2 | |
| 2025Q1 | 15.86 | 109.78 | -8.50 | -2,267 | -2 | |
| 2024Q4 | 25.25 | 98.93 | -3.76 | -1,941 | -2 | |
| 2024Q3 | 24.98 | 102.36 | -1.75 | -2,211 | -2 | |
| 2024Q2 | 28.75 | 102.28 | -7.75 | -2,287 | -2 | |
| 2024Q1 | 33.25 | 29.35 | -54.75 | -1,845 | -6 | |
| 2023Q4 | 46.50 | 104.27 | -18.50 | -1,784 | -2 | |
| 2023Q3 | 69.50 | 100.74 | -30.00 | -1,358 | -1 | |
| 2023Q2 | 130.13 | 97.88 | 27.25 | -1,477 | 1 | |
| 2023Q1 | 218.75 | 100.52 | -68.75 | -2,921 | -3 | |
| 2022Q4 | 134.38 | 112.71 | -69.25 | -5,055 | -3 | |
| 2022Q3 | 218.75 | 104.80 | -67.50 | -4,370 | -3 | |
| 2022Q2 | 837.50 | 99.56 | -99.75 | -3,830 | -4 | |
| 2022Q1 | 1256.25 | 105.19 | -81.25 | -3,059 | -3 | |
| 2021Q4 | 1687.50 | 100.95 | -175.00 | -5,981 | -6 | |
| 2021Q3 | 2681.25 | 94.12 | -131.25 | -4,064 | -4 | |
| 2021Q2 | 1593.75 | 99.17 | -156.25 | -4,404 | -4 | |
| 2021Q1 | 1512.50 | 100.14 | -187.50 | -4,840 | -5 |